MABELLA VACCINE - SCI & TECH

News: Indian Immunologicals launches measles and rubella vaccine for children

 

What's in the news?

       A live-attenuated MR vaccine named Mabella was launched in Udhagamandalam (Ooty), Tamil Nadu, as part of the 25th-anniversary celebrations of the Human Biologicals Institute (HBI), a division of the Indian Immunologicals Limited (IIL).

 

Key takeaways:

       Developed through an exclusive partnership with the Polyvac Institute of Vietnam, Mabella promises to be a crucial tool in the global fight against deadly measles and rubella.

 

Measles-Rubella (MR) Vaccination Campaign:

       The campaign was launched by the Union Ministry of Health and Family Welfare.

       It is an ambitious phased vaccination campaign that intends to cover more than 40 crore children.

 

Aim:

       The campaign is aimed at protecting the children from the two highly contagious viral diseases measles and rubella.

 

Measles:

       Measles kills almost 49000 Indian children annually. And, rubella (Congenital Rubella Syndrome or CRS) causes blindness and irreversible birth defects.

 

Treatment:

       While there are no treatment options available for both these diseases, they can be prevented by vaccinations.

       India is targeting the elimination of measles and rubella from the country. 

       Measles immunization will lead to a decrease in the rate of under-five mortality in India.

       Under the campaign, the vaccine will be provided free of cost to children.

       This is a massive public health movement and is being undertaken through coordinated efforts of the central and state governments, local governments, civil society and the healthcare workforce.

       Additionally, India also strengthens surveillance for measles and rubella, which is important learning from the country’s polio eradication program that helped to identify infected and vulnerable areas and populations and enabled the program to adopt appropriate strategies to eradicate the disease.

 

Measles and Rubella Vaccine:

       Five countries have eliminated measles – Bhutan, DPR Korea, Maldives, Sri Lanka and Timor-Leste.

       Six countries have controlled rubella – Bangladesh, Bhutan, Maldives, Nepal, Sri Lanka and Timor-Leste.

 

Elimination Status:

       A country is verified as having eliminated measles and rubella when there is no evidence of endemic transmission of the respective viruses for over three years in the presence of a well-performing surveillance system.